My watch list
my.bionity.com  

my.bionity.com

With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

Richard Clark (pharmacologist)



For people of the same name, please see Richard Clark.

  As of May 5th, 2005, Richard T. Clark is the CEO and president of Merck Pharmaceutical Company. From 2003 until May 2005, he was the head of the Merck Manufacturing Division (MMD).

Born in 1946, graduated from Washington & Jefferson College (1968), MBA from American University (1970), Lieutenant in US Army (1970-1972) employed by Merck since 1972.

v • d • e
Merck & Co., Inc.
Corporate Directors:Richard Clark · Johnnetta Cole · William Harrison · William Kelley · Rochelle Lazarus · Thomas Shenk · Anne Tatlock · Samuel Thier · Wendell Weeks · Peter Wendell
Products:Indinavir · Aprepitant · Alendronate · Rizatriptan · Finasteride · Losartan · Lovastatin · Montelukast · Rofecoxib · Ezetimibe/simvastatin · Ezetimibe · Raltegravir · Simvastatin · Sitagliptin · Vorinostat · The Merck Index · The Merck Manual
Annual Revenue: $22.9 billion USD (2% FY 2004) · Employees: 63,000 · Stock Symbol: NYSE: MRK · Website: www.merck.com
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Richard_Clark_(pharmacologist)". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE